Andrea Bussé

Dr. Andrea Bussé


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2020 in International Journal of Audiology
Verified
Journal Article
Open access
ABAndrea Bussé
Andrea Bussé
HHHans L. J. Hoeve
Hans L. J. Hoeve
KNKazem Nasserinejad
Kazem Nasserinejad
AMAllison R. Mackey
Allison R. Mackey
HSHuibert J. Simonsz
Huibert J. Simonsz
AGAndré Goedegebure
André Goedegebure
Objective: To investigate the variance in reported prevalence rates of permanent neonatal hearing impairment (HI) worldwide. Design: A systematic review and meta-analysis was performed on reported prevalence rates of sensorineural and permanent conductive or mixed HI worse than 40 dB in neonates, detected as a result of a screening programme or audiometric study. Study sample: For meta-analysis, 35 articles were selected, 25 from high-income countries and 10 from middle-income countries according to the world bank classification system. Results: The prevalence rate of permanent uni- and bilateral HI worse than 40 dB in neonates varied from 1 to 6 per 1000, the overall prevalence was 2.21 per 1000 [1.71, 2.8]. In NICU populations the prevalence rate was higher with a larger fraction of bilateral cases. Although not significant, prevalence rates were slightly higher in Asia compared to Europe and the number of infants lost to follow-up appeared higher in countries with lower gross national income. Conclusion: Substantial variations exist in prevalence rates of neonatal permanent HI across countries and regions. There is a strong need for more data from low-income countries to identify demographic factors that account for this variability in reported prevalence rates. Reporting these data in a uniform way is advocated.

10 March 2021 in International Journal of Audiology
Verified
Journal Article
Open access
ABAndrea Bussé
Andrea Bussé
AMAllison R. Mackey
Allison R. Mackey
HHHans L. J. Hoeve
Hans L. J. Hoeve
AGAndré Goedegebure
André Goedegebure
GCGwen Carr
Gwen Carr
FFFor The Eus€Reen Foundation
For The Eus€Reen Foundation
Newborn hearing screening (NHS) varies regarding number and type of tests, location, age, professionals and funding. We compared the provision of existing screening programmes.A questionnaire conta...

9 April 2021 in International Journal of Audiology
Verified
Journal Article
Open access
ABAndrea Bussé
Andrea Bussé
AMAllison R. Mackey
Allison R. Mackey
GCGwen Carr
Gwen Carr
HHHans L. J. Hoeve
Hans L. J. Hoeve
IUInger M. Uhlén
Inger M. Uhlén
FFFor The Eus€Reen Foundation
For The Eus€Reen Foundation
To inventory provision and features of childhood hearing screening after the newborn period (CHS), primarily in Europe.From each participating country or region, experts provided information throug...

8 April 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
ABAndrea Bussé
Andrea Bussé
BQBirkena Qirjazi
Birkena Qirjazi
AGAndré Goedegebure
André Goedegebure
MTMartijn Toll
Martijn Toll
HHHans Lj. Hoeve
Hans Lj. Hoeve
HSHuibert J. Simonsz
Huibert J. Simonsz
Objectives: The EUSCREEN study compares the cost-effectiveness of paediatric hearing screening programmes and aims to develop a cost-effectiveness model for this purpose. Alongside and informed by the development of the model, neonatal hearing screening (NHS) is implemented in Albania. We report on the first year. Methods: An implementation plan was made addressing objectives, target population, screening protocol, screener training, screening devices, care pathways and follow up. NHS started January 1st, 2018 in four maternity hospitals: two in Tirana, one in Pogradec and one in Kukës, representing both urban and rural areas. OAE-OAE-aABR was used to screen well infants in maternity hospitals, whereas aABR-aABR was used in neonatal intensive care units and in mountainous Kukës for all infants. Screeners’ uptake and attitudes towards screening and quality of screening were assessed by distributing questionnaires and visiting the maternity hospitals. The result of screening, diagnostics, follow up and entry into early intervention were registered in a database and monitored. Results: Screeners were keen to improve their skills in screening and considered NHS valuable for Albanian health care. The number of “fail” outcomes after the first screen was high initially but decreased to less than 10% after eight months. In 2018, 11,507 infants were born in the four participating maternity hospitals, 10,925 (94.9%) of whom were screened in the first step. For 486 infants the result of screening was not registered. For the first screen, ten parents declined, eight infants died and one infant was discharged before screening could be performed. In 1115 (10.2%) infants the test either could not be performed or the threshold was not reached; 361 (32,4%) of these did not attend the second screen. For the third screen 31 (34.4%) out of 90 did not attend. Reasons given were: parents declined (124), lived too far from screening location (95), their infant died (11), had other health issues (7), or was screened in private clinic (17), no reason given (138). Conclusions: Implementation of NHS in Albania is feasible despite continuing challenges. Acceptance was high for the first screen. However, 32.4% of 1115 infants did not attend the second screen, after a “fail” outcome for the first test.

Verified
Journal Article
Open access
PDF file
ABAndrea Bussé
Andrea Bussé
BQBirkena Qirjazi
Birkena Qirjazi
AMAllison Mackey
Allison Mackey
JKJan Kik
Jan Kik
AGAndré Goedegebure
André Goedegebure
HSHuibert Jan Simonsz
Huibert Jan Simonsz
Newborn hearing screening (NHS) was implemented in Albania in four maternity hospitals in 2018 and 2019. Implementation outcome, screening outcome, and screening quality measures were evaluated. Infants were first screened by midwives and nurses before discharge from the maternity hospital and returned for follow-up screening. Acceptability, appropriateness, feasibility, adoption, fidelity, coverage, attendance, and stepwise and final-referral rates were assessed by onsite observations, interviews, questionnaires, and a screening database. A post hoc analysis was performed to identify reasons for loss to follow up (LTFU) in a multivariate logistic regression. In total, 22,818 infants were born, of which 96.6% were screened. For the second screening step, 33.6% of infants were LTFU, 40.4% for the third, and 35.8% for diagnostic assessment. Twenty-two (0.1%) were diagnosed with hearing loss of ≥40 dB, six unilateral. NHS was appropriate and feasible: most infants are born in maternity hospitals, hence nurses and midwives could perform screening, and screening rooms and logistic support were supplied. Adoption among screeners was good. Referral rates decreased steadily, reflecting increasing skill. Occasionally, screening was repeated during a screening step, contrary to the protocol. NHS in Albania was implemented successfully, though LTFU was high. It is important to have effective data tracking and supervision throughout the screening.